368 related articles for article (PubMed ID: 17456755)
1. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
Kanetsuna Y; Takahashi K; Nagata M; Gannon MA; Breyer MD; Harris RC; Takahashi T
Am J Pathol; 2007 May; 170(5):1473-84. PubMed ID: 17456755
[TBL] [Abstract][Full Text] [Related]
2. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.
Zhao HJ; Wang S; Cheng H; Zhang MZ; Takahashi T; Fogo AB; Breyer MD; Harris RC
J Am Soc Nephrol; 2006 Oct; 17(10):2664-9. PubMed ID: 16971655
[TBL] [Abstract][Full Text] [Related]
3. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B
J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420
[TBL] [Abstract][Full Text] [Related]
4. eNOS deficiency predisposes podocytes to injury in diabetes.
Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
[TBL] [Abstract][Full Text] [Related]
5. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diabetic nephropathy between male and female eNOS
Ma Y; Li W; Yazdizadeh Shotorbani P; Dubansky BH; Huang L; Chaudhari S; Wu P; Wang LA; Ryou MG; Zhou Z; Ma R
Am J Physiol Renal Physiol; 2019 May; 316(5):F889-F897. PubMed ID: 30810354
[TBL] [Abstract][Full Text] [Related]
7. Knockout of Na
Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
[TBL] [Abstract][Full Text] [Related]
8. Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.
Miyazawa T; Zeng F; Wang S; Fan X; Cheng H; Yang H; Bian A; Fogo AB; Harris RC
Kidney Int; 2013 Dec; 84(6):1176-88. PubMed ID: 23760291
[TBL] [Abstract][Full Text] [Related]
9. Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice.
Cheng H; Wang H; Fan X; Paueksakon P; Harris RC
Kidney Int; 2012 Dec; 82(11):1176-83. PubMed ID: 22785174
[TBL] [Abstract][Full Text] [Related]
10. Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
Trachtman H; Futterweit S; Pine E; Mann J; Valderrama E
Pediatr Nephrol; 2002 Jan; 17(1):20-9. PubMed ID: 11793130
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell-specific overexpression of endothelial nitric oxide synthase in Ins2Akita mice exacerbates diabetic nephropathy.
Natarajan M; Habib SL; Reddick RL; Delma CR; Manickam K; Prihoda TJ; Werner SL; Mohan S
J Diabetes Complications; 2019 Jan; 33(1):23-32. PubMed ID: 30424931
[TBL] [Abstract][Full Text] [Related]
12. Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism.
You H; Gao T; Cooper TK; Morris SM; Awad AS
Kidney Int; 2013 Dec; 84(6):1189-97. PubMed ID: 23760286
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H
Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209
[TBL] [Abstract][Full Text] [Related]
14. Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse.
Tanabe K; Lanaspa MA; Kitagawa W; Rivard CJ; Miyazaki M; Klawitter J; Schreiner GF; Saleem MA; Mathieson PW; Makino H; Johnson RJ; Nakagawa T
Am J Physiol Renal Physiol; 2012 May; 302(9):F1151-60. PubMed ID: 22338086
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?
Balakumar P; Chakkarwar VA; Krishan P; Singh M
Biomed Pharmacother; 2009 Mar; 63(3):171-9. PubMed ID: 18823739
[TBL] [Abstract][Full Text] [Related]
16. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
[TBL] [Abstract][Full Text] [Related]
17. Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis.
Heeringa P; van Goor H; Itoh-Lindstrom Y; Maeda N; Falk RJ; Assmann KJ; Kallenberg CG; Jennette JC
Am J Pathol; 2000 Mar; 156(3):879-88. PubMed ID: 10702405
[TBL] [Abstract][Full Text] [Related]
18. Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy.
Boels MG; Avramut MC; Koudijs A; Dane MJ; Lee DH; van der Vlag J; Koster AJ; van Zonneveld AJ; van Faassen E; Gröne HJ; van den Berg BM; Rabelink TJ
Diabetes; 2016 Aug; 65(8):2429-39. PubMed ID: 27207530
[TBL] [Abstract][Full Text] [Related]
19. The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy.
Sato W; Kosugi T; Zhang L; Roncal CA; Heinig M; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Grant MB; Croker BP; Nakagawa T
Lab Invest; 2008 Sep; 88(9):949-61. PubMed ID: 18607348
[TBL] [Abstract][Full Text] [Related]
20. A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy.
Wang CH; Li F; Hiller S; Kim HS; Maeda N; Smithies O; Takahashi N
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):2070-5. PubMed ID: 21245338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
